Stewart F. Babbott, MD; Vincent E. Pearson, PharmD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Babbott S., Pearson V.; Sertraline-Related Night Sweats. Ann Intern Med. 1999;130:242-243. doi: 10.7326/0003-4819-130-3-199902020-00035
Download citation file:
Published: Ann Intern Med. 1999;130(3):242-243.
TO THE EDITOR:
A 24-year-old woman was evaluated for night sweats and dry cough that had progressed over 3 months. She had no history of fever, chills, or prior night sweats. She had noted fatigue, weakness, decreased appetite, and a 7-pound weight loss over the past 6 months. She had infrequent postnasal drip and mild seasonal allergies. She reported no tobacco use, gastroesophageal reflux, upper or lower respiratory tract infection symptoms, dyspnea, diarrhea, risk factors for HIV infection, adenopathy, recent travel, or use of nonprescription medication. She had been exposed to tuberculosis as a volunteer in an HIV clinic, and had a negative result on a purified protein derivative test 1 year earlier. She was under care for depression, with gradual increases in the sertraline dose over the preceding 3 months. Her medications were sertraline, 150 mg daily, and an oral contraceptive. Physical examination was unremarkable. Laboratory data included a negative HIV test result; negative result on a test for mononucleosis; negative result on a purified protein derivative test; and normal thyroid-stimulating hormone level, erythrocyte sedimentation rate, chemistry panel, complete blood count, chest radiograph, and computed tomographic scan of the abdomen.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only